Adaptimmune Therapeutics PLC reports results for the quarter - Earnings Summary

Adaptimmune Therapeutics

14/11/2024 03:54

* Adaptimmune Therapeutics PLC  ADAP.OQ  reported a
quarterly
adjusted loss of 1 cent​​ per share for the quarter , higher
than the same quarter last year, when the company reported EPS
of -20 cents.  The mean expectation of seven analysts for the
quarter was for a loss of 13 cents per share. Wall Street
expected results to range from -22 cents to -1 cents per share.
    * Revenue rose 458.8% to $40.90 million from a year ago;
analysts
expected $11.17 million. 
    * Adaptimmune Therapeutics PLC's reported EPS for the
quarter was
a loss of 1 cent​.
    * The company reported a quarterly loss of $17.62 million.
    * Adaptimmune Therapeutics PLC shares had fallen by 16.5%
this
quarter and gained 0.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 13.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Adaptimmune
Therapeutics PLC is 2.50 
This summary was machine generated from LSEG data November 14 at
03:54 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.13          -0.01          Beat
 Jun. 30 2024      -0.07          0.24           Beat
 Mar. 31 2024      -0.10          -0.18          Missed
 Dec. 31 2023      -0.10          -0.24          Missed